Related Experiment Video
Updated: Jun 14, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Implication of IL-12A, IL-12B, IL-6, and TNF single-nucleotide polymorphisms in severity and susceptibility to
R Benmansour1, M R Tagajdid1, I A Lahlou1
1Center of Virology, Infectious and Tropical Diseases, Mohamed V Military Teaching Hospital, University Mohammed V in Rabat, Rabat, Morocco.
Insights
Genetic factors influencing COVID-19 outcomes were studied. While most gene polymorphisms showed no link to COVID-19 severity, a specific Interleukin-6 (IL-6) variant suggested a protective effect against SARS-CoV-2 infection.
Area of Science:
- Immunogenetics
- Genomics
- Infectious Disease Epidemiology
Background:
- The COVID-19 pandemic caused significant global health issues.
- Understanding genetic influences on disease severity is crucial for pathogenesis insights and therapeutic strategies.
Purpose of the Study:
- To investigate the association between single nucleotide polymorphisms (SNPs) in IL-12A, IL-12B, IL-6, and TNF genes and COVID-19 severity and susceptibility in Moroccan patients.
Main Methods:
- Next-Generation Sequencing (NGS) was performed on 325 Moroccan participants (207 COVID-19 patients, 118 controls).
- Statistical analysis utilized logistic regression models to assess correlations with disease severity and susceptibility.
Main Results:
- No significant association was found between SNPs in IL-12A, IL-12B, IL-6, or TNF and overall COVID-19 severity or susceptibility.
- A specific IL-6 SNP (rs2069840) showed a negative correlation, indicating a potential protective effect against SARS-CoV-2 infection.
Conclusions:
- Polymorphisms in IL-12A, IL-12B, IL-6, and TNF genes do not appear to be correlated with COVID-19 severity or susceptibility.
- The rs2069840 polymorphism in IL-6 may offer a protective effect against SARS-CoV-2 infection, warranting further investigation.
Background:
The Coronavirus Disease 2019 (COVID-19) pandemic has led to significant global morbidity and mortality. Understanding the genetic factors that influence disease outcomes can provide critical insights into pathogenesis and potential therapeutic targets.
Objective:
This study aimed to investigate the potential correlation between single nucleotide polymorphisms (SNPs) in Interleukin 12 Subunit Alpha (IL-12A), Interleukin 12 Subunit Beta (IL-12B), Interleukin 6 (IL-6), and Tumor Necrosis Factor (TNF) genes and the severity as well as susceptibility to COVID-19 among Moroccan patients.
Patients And Methods:
Next-Generation sequencing (NGS) was conducted on 325 Moroccan participants, 207 patients with PCR-confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and 118 controls. Among these patients, 51% presented moderate to severe symptoms requiring hospitalization, while 49% were asymptomatic or experienced mild symptoms and did not require hospitalization. Statistical analysis was performed using codominant, dominant, and recessive logistic regression models to assess correlations with the severity and susceptibility to COVID-19 infection.
Results:
No association was found between SNPs of IL-12A, IL-12B, IL-6 or TNF and COVID-19 severity and susceptibility. However, our results unveiled a noteworthy association with IL-6 rs2069840, which exhibited a negative correlation (OR = 0.21, 95% CI = 0.07-0.69, p = .006), suggesting a protective effect against SARS-CoV-2 infection.
Conclusion:
Polymorphisms in IL-12A, IL-12B, IL-6, and TNF genes are not correlated to the severity and susceptibility of COVID-19.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway

